If a stock manages to record significant gains over the course of several weeks, then it may be a good idea for investors to start taking a closer look. In the past month, the Sernova Corp (OTCMKTS:SEOVF) stock has been one of the major movers in the market and has managed to record gains of as much as 52%.
Trading Data
On Wednesday, SEOVF stock moved up 1.03% to $1.5357 with more than 126k shares, compared to its average volume of 53K shares. The stock has moved within a range of $1.4729 – 1.6210 after opening trade at $1.60 .
New Interim Results of its Type 1 Diabetes Clinical Trial
Considering the fact that the stock has made such a strong move, it may now be the right time for investors to take a look at the development with regards to the company yesterday. The company announced yesterday that it was going to make an announcement with regards to the interim results related to the tolerability, safety and efficacy in the Phase I/II clinical trial of its Cell Pouch product.
Sernova Corp noted that it was going to release those results on January 10, 2022. The announcement of the date was an important development for the company and it now remains to be seen if it leads to further interest in the Sernova stock among investors. The results are going to be declared at the same time as the J.P. Morgan conference, which is one of the major global healthcare conference at this point.
Technical Data
SEOVF stock is trading above the 10-Day and 20-Day Moving averages of $1.45 and $1.28 respectively. Moreover, the stock is trading above the 200-Day moving average of $1.11.
